Human bocavirus type-1 capsid facilitates the transduction of ferret airways by adeno-associated virus genomes

Human Gene Therapy

Volumn 28, Issue 8, 2017, Pages 612-625

  Yan, Ziying ^a,b   Feng, Zehua ^a   Sun, Xingshen ^a   Zhang, Yulong ^a   Zou, Wei ^c   Wang, Zekun ^c   Jensen Cody, Chandler ^a   Liang, Bo ^a   Park, Soo Yeun ^a   Qiu, Jianming ^c   Engelhardt, John F ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

airway transduction; newborn and juvenile ferret; rAAV2 HBoV1 vector

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR; HUMAN BOCAVIRUS TYPE 1 VECTOR; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG; CAPSID PROTEIN;

ADENO ASSOCIATED VIRUS 2; AIRWAY; AIRWAY EPITHELIUM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENDOCYTOSIS; EX VIVO STUDY; GENE EXPRESSION; GENE THERAPY; HEK293 CELL LINE; HUMAN; HUMAN BOCAVIRUS; HUMAN BOCAVIRUS TYPE 1; HUMAN CELL; IN VITRO STUDY; IN VIVO GENE TRANSFER; IN VIVO STUDY; MUSTELA PUTORIUS FURO; NEWBORN; NONHUMAN; REINFECTION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL TROPISM; VIRUS CAPSID; VIRUS GENOME; VIRUS RECOMBINANT; WEIGHT GAIN; XENOGRAFT; ANIMAL; CELL LINE; DEPENDOPARVOVIRUS; EPITHELIUM CELL; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; LUNG; METABOLISM; MOUSE; PARVOVIRINAE; REPORTER GENE; RESPIRATORY MUCOSA; TIME FACTOR; VIROLOGY;

ANIMALS; CAPSID PROTEINS; CELL LINE; DEPENDOVIRUS; EPITHELIAL CELLS; FERRETS; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; HETEROGRAFTS; HUMAN BOCAVIRUS; HUMANS; LUNG; MICE; PARVOVIRINAE; RESPIRATORY MUCOSA; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 85027409251     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2017.060     Document Type: Article

References (70)

1. O Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009; 373: 1891-1904.
2. Rowe SM, Clancy JP. Advances in cystic fibrosis therapies. Curr Opin Pediatr 2006; 18: 604-613.
3. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
4. Collins FS. Cystic fibrosis: molecular biology and therapeutic implications. Science 1992; 256: 774-779.
5. van Gool K, Norman R, Delatycki MB, et al. Understanding the costs of care for cystic fibrosis: an analysis by age and health state. Value Health 2013; 16: 345-355.
6. Driskell RA, Engelhardt JF. Current status of gene therapy for inherited lung diseases. Annu Rev Physiol 2003; 65: 585-612.
7. Prickett M, Jain M. Gene therapy in cystic fibrosis. Transl Res 2013; 161: 255-264.
8. Griesenbach U, Pytel KM, Alton EW. Cystic fibrosis gene therapy in the UK and elsewhere. Hum Gene Ther 2015; 26: 266-275.
9. Carter BJ. Adeno-Associated virus vectors in clinical trials. Hum Gene Ther 2005; 16: 541-550.
10. Samulski RJ, Muzyczka N. AAV-mediated gene therapy for research and therapeutic purposes. Annu Rev Virol 2014; 1: 427-451.
11. Aitken ML, Moss RB, Waltz DA, et al. A Phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum Gene Ther 2001; 12: 1907-1916.
12. Moss RB, Milla C, Colombo J, et al. Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled Phase 2B trial. Hum Gene Ther 2007; 18: 726-732.
13. Duan D, Yue Y, Yan Z, et al. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-Associated virus. J Clin Invest 2000; 105: 1573-1587.
14. Yan Z, Zak R, Zhang Y., et al. Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-Associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia. J Virol 2004; 78: 2863-2874.
15. Ding W, Zhang L, Yan Z, et al. Intracellular trafficking of adeno-Associated viral vectors. Gene Ther 2005; 12: 873-880.
16. Dong JY, Fan PD, Frizzell RA. Quantitative analysis of the packaging capacity of recombinant adenoassociated virus. Hum Gene Ther 1996; 7: 2101-2112.
17. Zhang L, Wang D, Fischer H, et al. Efficient expression of CFTR function with adeno-Associated virus vectors that carry shortened CFTR genes. Proc Natl Acad Sci U S A 1998; 95: 10158-10163.
18. Yan Z, Sun X, Feng Z, et al. Optimization of recombinant adeno-Associated virus-mediated expression for large transgenes, using a synthetic promoter and tandem array enhancers. Hum Gene Ther 2015; 26: 334-346.
19. Kwilas AR, Yednak MA, Zhang L, et al. Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro. J Virol 2010; 84: 7770-7781.
20. Ferrari S, Griesenbach U, Iida A, et al. Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther 2007; 14: 1371-1379.
21. Allander T, Tammi MT, Eriksson M, et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A 2005; 102: 12891-12896.
22. Allander T, Jartti T, Gupta S, et al. Human bocavirus and acute wheezing in children. Clin Infect Dis 2007; 44: 904-910.
23. Qiu J, Soderlund-Venermo M, Young NS. Human parvoviruses. Clin Microbiol Rev 2017; 30: 43-113.
24. Jartti T, Hedman K, Jartti L, et al. Human bocavirus-The first 5 years. Rev Med Virol 2012; 22: 46-64.
25. Meriluoto M, Hedman L, Tanner L, et al. Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland. Emerg Infect Dis 2012; 18: 264-271.
26. Cotmore SF, Agbandje-McKenna M, Chiorini JA, et al. The family Parvoviridae. Arch Virol 2014; 159: 1239-1247.
27. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350: 586-597.
28. Huang Q, Deng X, Yan Z, et al. Establishment of a reverse genetics system for studying human bocavirus in human airway epithelia. PLoS Pathog 2012; 8: e1002899.
29. Shen W, Deng X, Zou W, et al. Identification and functional analysis of novel nonstructural proteins of human bocavirus 1. J Virol 2015; 89: 10097-10109.
30. Deng X, Yan Z, Cheng F, et al. Replication of an autonomous human parvovirus in non-dividing human airway epithelium is facilitated through the DNA damage and repair pathways. PLoS Pathog 2016; 12: e1005399.
31. Shen W, Deng X, Zou W, et al. Analysis of cis and trans requirements for DNA replication at the right-end hairpin of the human bocavirus 1 genome. J Virol 2016; 90: 7761-7777.
32. Zou W, Cheng F, Shen W, et al. Nonstructural protein NP1 of human bocavirus 1 plays a critical role in the expression of viral capsid proteins. J Virol 2016; 90: 4658-4669.
33. Deng X, Xu P, Zou W, et al. DNA Damage Signaling Is Required for Replication of Human Bocavirus 1 DNA in Dividing HEK293 Cells. J Virol 2017; 91: e01831-16.
34. Wang Z, Shen W, Cheng F, et al. Parvovirus expresses a small noncoding RNA that plays an essential role in virus replication. J Virol 2017; 91: e02375-16.
35. Deng X, Yan Z, Luo Y, et al. In vitro modeling of human bocavirus 1 infection of polarized primary human airway epithelia. J Virol 2013; 87: 4097-4102.
36. Yan Z, Keiser NW, Song Y, et al. A novel chimeric adenoassociated virus 2/human bocavirus 1 parvovirus vector efficiently transduces human airway epithelia. Mol Ther 2013; 21: 2181-2194.
37. Rogers CS, Hao Y, Rokhlina T, et al. Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-Associated virus-mediated gene targeting and somatic cell nuclear transfer. J Clin Invest 2008; 118: 1571-1577.
38. Sun X, Yan Z, Yi Y, et al. Adeno-Associated virustargeted disruption of the CFTR gene in cloned ferrets. J Clin Invest 2008; 118: 1578-1583.
39. Keiser NW, Engelhardt JF. New animal models of cystic fibrosis: what are they teaching us? Curr Opin Pulm Med 2011; 17: 478-483.
40. Yan Z, Stewart ZA, Sinn PL, et al. Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy. Hum Gene Ther Clin Dev 2015; 26: 38-49.
41. Karp PH, Moninger TO, Weber SP, et al. An in vitro model of differentiated human airway epithelia. Methods for establishing primary cultures. Methods Mol Biol 2002; 188: 115-137.
42. Liu X, Luo M, Zhang L, et al. Bioelectric properties of chloride channels in human, pig, ferret, and mouse airway epithelia. Am J Respir Cell Mol Biol 2007; 36: 313-323.
43. Yan Z, Sun X, Evans IA, et al. Postentry processing of recombinant adeno-Associated virus type 1 and transduction of the ferret lung are altered by a factor in airway secretions. Hum Gene Ther 2013; 24: 786-796.
44. Keiser NW, Engelhardt JF. Gene delivery to the airway. Curr Protoc Hum Genet 2013; Chapter 13: Unit 13 19.
45. Wang X, Zhang Y, Amberson A, et al. Newmodels of the tracheal airway define the glandular contribution to airway surface fluid and electrolyte composition. Am J Respir Cell Mol Biol 2001; 24: 195-202.
46. Dajani R, Zhang Y, Taft PJ, et al. Lysozyme secretion by submucosal glands protects the airway from bacterial infection. Am J Respir Cell Mol Biol 2005; 32: 548-552.
47. Engelhardt JF, Schlossberg H, Yankaskas JR, et al. Progenitor cells of the adult human airway involved in submucosal gland development. Development 1995; 121: 2031-2046.
48. Sun X, Olivier AK, Liang B, et al. Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets. Am J Respir Cell Mol Biol 2014; 50: 502-512.
49. Sun X, Sui H, Fisher JT, et al. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest 2010; 120: 3149-3160.
50. Keiser NW, Birket SE, Evans IA, et al. Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs. Am J Respir Cell Mol Biol 2015; 52: 683-694.
51. Don M, Soderlund-Venermo M, Valent F, et al. Serologically verified human bocavirus pneumonia in children. Pediatr Pulmonol 2010; 45: 120-126.
52. Nayak S, Herzog RW. Progress and prospects: immune responses to viral vectors. Gene Ther 2010; 17: 295-304.
53. Sumner-Jones SG, Gill DR, Hyde SC. Lack of repeat transduction by recombinant adenoassociated virus type 5/5 vectors in the mouse airway. J Virol 2007; 81: 12360-12367.
54. Halbert CL, Standaert TA, Wilson CB, et al. Successful readministration of adeno-Associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol 1998; 72: 9795-9805.
55. Limberis MP, Wilson JM. Adeno-Associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc Natl Acad Sci U S A 2006; 103: 12993-12998.
56. Jula A, Waris M, Kantola K, et al. Primary and secondary human bocavirus 1 infections in a family, Finland. Emerg Infect Dis 2013; 19: 1328-1331.
57. Ghietto LM, Camara A, Camara J, et al. High frequency of human bocavirus 1 DNA in infants and adults with lower acute respiratory infection. J Med Microbiol 2012; 61: 548-551.
58. Yi Y, Sun X, Gibson-Corley K, et al. A transient metabolic recovery from early life glucose intolerance in cystic fibrosis ferrets occurs during pancreatic remodeling. Endocrinology 2016; 157: 1852-1865.
59. Zhao B, Yu X, Wang C, et al. High human bocavirus viral load is associated with disease severity in children under five years of age. PLoS One 2013; 8: e62318.
60. Hinderer C, Bell P, Louboutin JP, et al. Neonatal systemic AAV induces tolerance to CNS gene therapy in MPS I dogs and nonhuman primates. Mol Ther 2015; 23: 1298-1307.
61. Fan X, Ang A, Pollock-Barziv SM, et al. Donorspecific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 2004; 10: 1227-1233.
62. Adkins B. T-cell function in newborn mice and humans. Immunol Today 1999; 20: 330-335.
63. Yan Z, Lei-Butters DC, Liu X, et al. Unique biologic properties of recombinant AAV1 transduction in polarized human airway epithelia. J Biol Chem 2006; 281: 29684-29692.
64. Yan Z, Zak R, Luxton GW, et al. Ubiquitination of both adeno-Associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J Virol 2002; 76: 2043-2053.
65. Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 2009; 9: 338-350.
66. Fekete MR, McBride WH, Pajonk F. Anthracyclines, proteasome activity and multi-drugresistance. BMC Cancer 2005; 5: 114.
67. Eckert R, Gruner S, Volk HD, et al. Studies on the immunomodulatory effects of anthracycline antibiotics in mice: effects on immune responses and graft immunogenicity. Immunobiology 1989; 179: 445-455.
68. Finn JD, Hui D, Downey HD, et al. Proteasome inhibitors decrease AAV2 capsid derived peptide epitope presentation on MHC class I following transduction. Mol Ther 2010; 18: 135-142.
69. Berges C, Haberstock H, Fuchs D, et al. Proteasome inhibition suppresses essential immune functions of human CD4+ T cells. Immunology 2008; 124: 234-246.
70. Luo H, Wu Y, Qi S, et al. A proteasome inhibitor effectively prevents mouse heart allograft rejection. Transplantation 2001; 72: 196-202.